

"A global clinical research organization accelerating multi-regional trials for biopharma innovators"
Caidya is a global clinical research organization partnering with biopharma innovators to bring life changing therapies to patients. Operating in 40 countries, it provides solutions from early to Phase II/III studies, regulatory services, and data management. With expertise in oncology, rare diseases, and gene therapy, Caidya provides tailored solutions. Formed in 2021 through the merger of dMed and Clinipace, Caidya brings nearly 1,800 professionals to each study. Operating as an extension of client teams, the organization takes ownership to solve issues, reduce risk, and deliver high quality data. Through transparent communication and proactive planning, Caidya helps companies navigate trials and accelerate therapies to patients.


1800
Team Members
2004
Founded
Contract Research
Sector
Hybrid
Work Environment
A world where every potential therapy has the best opportunity to reach patients in need through liberated clinical research that breaks barriers and elevates the customer experience.
Liberating clinical research through listening for understanding, thinking openly, owning the success of each project we conduct, and sharing our knowledge every step of the way.